Surfing the MASH Tsunami

Surfing the MASH Tsunami

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(1073)

International NASH Day is Here! - Ep 9

International NASH Day is Here! - Ep 9

Send us Fan Mail Surfing the NASH Tsunami celebrates a growing and increasingly important global event for the Fatty Liver community. Global Liver Institute President & CEO Donna Cryer joins the Surf...

11 Jun 202054min

Diagnosing Diagnostics – Part I - Ep 8

Diagnosing Diagnostics – Part I - Ep 8

Send us Fan Mail Room for improvement GenFit Head of Global Diagnostics Suneil Hosmane joins the Surfers in exploring the current strengths and drawbacks of Fatty Liver diagnostics. The conversation ...

4 Jun 202050min

NASH-Ville - Part 2: Better Days Ahead? - Ep 7

NASH-Ville - Part 2: Better Days Ahead? - Ep 7

Send us Fan Mail Reviewing press releases reporting preliminary findings from six recently announced Phase 2 trials Stephen Harrison leads the Surfers, with guest Louise Campbell, through an examinat...

28 Mai 20201h 1min

What’s in a Name: NAFLD or MAFLD? - Ep 6

What’s in a Name: NAFLD or MAFLD? - Ep 6

Send us Fan Mail Exploring the controversy over the name(s) to use when describing Fatty Liver disease(s) Professor Quentin Anstee joins the Surfers for a thoughtful consideration of the factors that...

21 Mai 202052min

Wild Times In NASH-Ville – Part I - Ep 5

Wild Times In NASH-Ville – Part I - Ep 5

Send us Fan Mail Clinical trial results that are changing how we look at NASH Stephen Harrison leads a review of two recent Phase 3 data statements: the outcome of GenFit’s RESOLVE-IT trial and Madri...

15 Mai 20201h 3min

When You Get To A Fork In The Road - Ep 4

When You Get To A Fork In The Road - Ep 4

Send us Fan Mail Three possible scenarios for development of the NASH market. Roger Green presents three possible directions for the NASH market over the next 5-10 years and asks our panelists, includ...

7 Mai 202059min

C-Suite COVID-19 Challenges - Ep 3

C-Suite COVID-19 Challenges - Ep 3

Send us Fan Mail Critical considerations for companies developing NASH drugs Peter Traber focuses on ways COVID-19 can affect drug development and broader corporate strategies while our panelists wei...

30 Apr 202053min

Five $imple Pieces - Ep 2

Five $imple Pieces - Ep 2

Send us Fan Mail What investors want to know about NASH development during the pandemic. Yasmeen Rahimi poses five questions NASH investors ask her about the impact of COVID-19 on NASH clinical and c...

23 Apr 202054min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
forskningno
sinnsyn
villmarksliv
liberal-halvtime
rss-paradigmepodden
rekommandert
tomprat-med-gunnar-tjomlid
fjellsportpodden
dekodet-2
aldring-og-helse-podden
rss-rekommandert
rss-inn-til-kjernen-med-sunniva-rose
diagnose
vett-og-vitenskap-med-gaute-einevoll
kvinnehelsepodden
rss-overskuddsliv
hva-er-greia-med